TAYLOR ROSE: Open Payments
NPI 1972067908 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$681 in 13 payments from 9 companies in 2025. Trend: 2023 $225 · 2024 $103 · 2025 $681
Food & beverage: $681
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $226 |
| IMMUNITYBIO, INC. | 1 | $147 |
| E.R. Squibb & Sons, L.L.C. | 1 | $114 |
| Boston Scientific Corporation | 2 | $60 |
| Janssen Scientific Affairs, LLC | 1 | $52 |
| Janssen Biotech, Inc. | 1 | $24 |
| Teleflex LLC | 1 | $24 |
| Caris MPI, Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
Products named: ANKTIVA, OPDIVO, ERLEADA, SpaceOAR System, UROLIFT, MI CANCER SEEK, ORGOVYX.
Industry payments across MD — which companies pay providers there.
